Head-to-head
Amble Health vs Direct Meds
Compared on tirzepatide across the eight dimensions this database records. They differ on 6 of those eight. Amble Health is cheaper on all-in tirzepatide at 10 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
Amble Health is $300 a month all-in for tirzepatide; Direct Meds is $399. Over twelve months that is $3,600 against $4,788. Value Scores are 67.2 and 45.1 out of 100.
Tirzepatide
Plan pages: Amble Health plans · Direct Meds plans
At 10 mg/week, Amble Health is $300 a month all-in and Direct Meds is $399 — $99 apart, or $1,188 across a year. Over twelve months the totals are $3,600 (billed monthly) and $4,788 (billed monthly).
Amble Health charges a flat $300 per month for tirzepatide at every dose from 2.5 to 15 mg per week, so titrating upward does not change what you pay.
Direct Meds prices tirzepatide by dose: $299 per month at 2.5 mg rising to $399 at 10 mg, a difference of $100 a month between the bottom and top of the ladder. The company publishes no price at 5, 7.5, 12.5, 15 mg, so those doses are left blank rather than estimated.
| Dose | Amble Health | Rank | Direct Meds | Rank | Cheaper |
|---|---|---|---|---|---|
| 2.5 mg | $300 | 21/31 | $299 | 17/31 | Direct Meds by $1 |
| 5 mg | $300 | 11/17 | — | — | only Amble Health publishes |
| 7.5 mg | $300 | 11/17 | — | — | only Amble Health publishes |
| 10 mg | $300 | 15/27 | $399 | 20/27 | Amble Health by $99 |
| 12.5 mg | $300 | 11/17 | — | — | only Amble Health publishes |
| 15 mg | $300 | 11/17 | — | — | only Amble Health publishes |
The lead changes with the dose. Between 2.5 mg and 10 mg it passes to Amble Health. Pick on the dose you expect to settle at, not the headline.
Across the 27 programs this database can rank on tirzepatide, Amble Health sits 13 of 27 on all-in monthly cost and Direct Meds sits 22. There are 8 other programs priced between them. The field median is $339 and the floor is $169, so Amble Health is below the median and the other is above it. Amble Health is $131 above the cheapest tirzepatide program on record. Direct Meds is $230 above the cheapest tirzepatide program on record.
LillyDirect (Zepbound), the lowest FDA-approved tirzepatide channel here, is $449 a month — Amble Health undercuts it by $149, Direct Meds by $50. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | Amble Health | Direct Meds | Cheaper |
|---|---|---|---|
| Month to month | $300 | $399 | Amble Health by $99 |
| Settled dose | Amble Health | Direct Meds | Difference |
|---|---|---|---|
| 2.5 mg | $3,600 | $3,588 | $12 apart |
| 5 mg | $3,600 | — | one side unpriced |
| 7.5 mg | $3,600 | — | one side unpriced |
| 10 mg | $3,600 | $4,788 | $1,188 apart |
| 12.5 mg | $3,600 | — | one side unpriced |
| 15 mg | $3,600 | — | one side unpriced |
Amble Health publishes no rate for 3-month term, 6-month term, 12-month term; Direct Meds publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 10 mg/week, the first twelve months work out to $3,600 on Amble Health and $4,688 on Direct Meds — $1,088 apart, and a different gap from the $1,188 you would get by multiplying the monthly difference by twelve. The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.
That calculation is partial: Direct Meds publishes no price at 2 of them, so the maintenance rate stands in for the missing steps rather than a number the company has stated.
Value Scores are 67.2 for Amble Health and 45.1 for Direct Meds, against a tirzepatide category floor of $169. Amble Health leads by 22.1 points, and the margin comes from structure rather than price alone.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| Amble Health | 39.4 | 12.8 | 10 | 5 | 67.2 |
| Direct Meds | 29.6 | 10.5 | 0 | 5 | 45.1 |
Where the two programs differ
All-in monthly
Amble Health is cheaper month to month — $300 against $399, a gap of $99 every month, or $1,188 across a year if both rates hold.
Cancellation terms
Cancellation differs: Amble Health states Cancel before renewal, while Direct Meds states Per provider terms. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Commitment
Amble Health asks for Month-to-month; Direct Meds asks for Monthly (no commitment indicated). This is the dimension most likely to change which program is actually cheaper for you, because the lowest rates on both sides are usually attached to the longest terms.
Dose policy
Amble Health charges one price at every dose; Direct Meds prices by dose. That difference usually matters more than the headline gap, because the tiered program's advertised figure describes the dose you start on, not the dose you settle at.
Evidence status
The two prices are not equally well evidenced. Amble Health's figure is provider-stated and Direct Meds's is reported. Amble Health rests on the stronger of the two, and the Value Score below reflects that — evidence quality is worth fifteen points and is not a tiebreaker we apply after the fact.
Twelve-month cost
Over twelve months the totals are $3,600 for Amble Health and $4,788 for Direct Meds. Amble Health is lower by $1,188 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Membership fee
Neither charges a separate membership fee.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
Amble Health Official site
A no-membership program with $300/month flat tirzepatide.
It does not publicly name its compounding pharmacy; the record shows Partner pharmacies, so who actually makes the medication cannot be independently verified; commitment terms are Month-to-month; cancellation is Cancel before renewal; availability is stated as Availability at intake.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — amblehealth.com pricing capture 2026-08-05
Watch: Provider-stated; checkout capture pending.
Direct Meds Official site
Direct Meds offers compounded GLP-1s in multiple formats — sublingual and injectable — with all-inclusive pricing verified on its own product pages. Semaglutide runs $249–$297/mo and tirzepatide $299–$399/mo depending on format; the lower figures are for sublingual delivery.
It does not publicly name its compounding pharmacy; the record shows Partner 503A pharmacy (not publicly named), so who actually makes the medication cannot be independently verified; commitment terms are Monthly (no commitment indicated); cancellation is Per provider terms; availability is stated as Confirm at intake.
Evidence: reported — sourced from dated third-party reporting; first-party capture pending, captured . Source — rangeyourself.com, Direct Meds product pages verified 2026-07-25
Watch: Pricing varies by format and page; product-page 'all-inclusive' rates differ from homepage promo cards. Rank is based on injectable rate as primary. Reported status — RangeYourself verified 2026-07-25 on Direct Meds' own product pages.
Which molecules each one carries
Amble Health carries tirzepatide at $300 a month; does not offer semaglutide.
Direct Meds carries tirzepatide at $399 a month and semaglutide at $297 a month.
Comparable only on tirzepatide: they do not both publish a rankable semaglutide price. Switching molecule mid-treatment would mean changing provider.
What neither record tells you
Amble Health does not publish
- no published twelve-month tirzepatide rate
- no named compounding pharmacy
Direct Meds does not publish
- no tirzepatide price at 5, 7.5, 12.5, 15 mg per week
- no published twelve-month tirzepatide rate
- no named compounding pharmacy
- no state-by-state availability list — it says Confirm at intake
- no specific cancellation or refund terms
Ask Amble Health and Direct Meds for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Evidence may be upgraded. Direct Meds carries a price we have not captured at checkout. A capture would move the evidence term and could reorder these two without any price changing.
Which one suits which reader
On the lowest standing monthly rate for tirzepatide, Amble Health Official site wins this matchup. If you expect to titrate to the top of the ladder, amble health's flat pricing is worth more than the headline gap suggests; and if you would rather trust a better-evidenced number, amble health's price rests on stronger provenance.
Both figures should be checked at the provider's own checkout before you pay. Amble Health's tirzepatide price is provider-stated as of 2026-08-05; Direct Meds's is reported as of 2026-07-25.
Questions
Is Amble Health or Direct Meds cheaper for tirzepatide?
Amble Health is cheaper on all-in monthly cost at 10 mg/week: $300 against $399, a difference of $99 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of Amble Health versus Direct Meds?
Amble Health works out to $3,600 across twelve months and Direct Meds to $4,788, on the plan terms each publishes.
Does Amble Health or Direct Meds raise the price as the dose goes up?
Amble Health: no, it charges one flat rate at every dose. Direct Meds: yes, it prices by dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do Amble Health and Direct Meds differ?
6 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of Amble Health and Direct Meds names its pharmacy?
Neither. Amble Health records Partner pharmacies and Direct Meds records Partner 503A pharmacy (not publicly named). Without a named pharmacy, neither program's licensing or inspection history can be checked before you order.
How well evidenced are the Amble Health and Direct Meds prices?
Amble Health's tirzepatide figure is provider-stated — taken from the provider's own published pages; checkout capture pending — captured 2026-08-05. Direct Meds's is reported, captured 2026-07-25. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Official sources: Amble Health official site · Direct Meds official site. Compounded tirzepatide and semaglutide are not FDA-approved products.